Imatinib as a Paradigm of Targeted Therapies
Author:
Publisher
Elsevier
Reference102 articles.
1. Lymphosarcoma: Virus-induced thymic-independent disease in mice;Abelson;Cancer Res.,1970
2. High incidence of BCR-ABL kinase domain mutations in CML patients with secondary resistance to imatinib;Al-Ali;Hematol. J.,2004
3. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor β;Apperley;N. Engl. J. Med.,2002
4. Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571;Barthe;Br. J. Haematol.,2002
5. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr⧸abl hybrid gene;Ben-Neriah;Science,1986
Cited by 309 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology;European Journal of Medicinal Chemistry Reports;2024-12
2. Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications;Seminars in Cancer Biology;2024-11
3. Design, in silico Evaluation, and Determination of Antitumor Activity of Potential Inhibitors Against Protein Kinases: Application to BCR-ABL Tyrosine Kinase;Biochemistry (Moscow);2024-06
4. A Targetable Receptor Tyrosine Kinase in Metastatic Pheochromocytoma and Paraganglioma: A Future Journey for Anlotinib?;Journal of the Endocrine Society;2024-05-07
5. Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9;Personalized Medicine;2024-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3